It has previously been shown that podocalyxin expression in invasive breast carcinoma correlates with poor patient survival and that podocalyxin enhances the motility and invasiveness of breast cancer cell lines in vitro [10,19-21]. The gene discussed is PODXL; the disease is invasive breast carcinoma.